Primary Prevention of Stroke in Children With SCD in Sub-Saharan Africa II (SPRING)
Primary Prevention of Stroke in Children With Sickle Cell Disease in Sub-Saharan Africa II
Sponsor: Aminu Kano Teaching Hospital
This PHASE3 trial investigates Sickle Cell Disease and Stroke and is currently completed. Aminu Kano Teaching Hospital leads this study, which shows 10 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Sep 2020 — Jan 2021 [monthly]
Completed PHASE3
-
Jun 2020 — Sep 2020 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
▶ Show 5 earlier versions
-
Jun 2019 — Jun 2020 [monthly]
Active Not Recruiting PHASE3
-
Sep 2018 — Jun 2019 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE3
-
Apr 2017 — Jun 2018 [monthly]
Recruiting PHASE3
-
Jan 2017 — Apr 2017 [monthly]
Recruiting PHASE3
First recorded
Jul 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aminu Kano Teaching Hospital
- Barau Dikko Teaching Hospital/Kaduna State University
- Murtala Muhammed Specialist Hospital
- National Institute of Neurological Disorders and Stroke (NINDS)
- Vanderbilt University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .